Patients with atheromatous plaques of the thoracic aorta undergoing coronary angiography are subjected to a substantial risk of catheter-related stroke or peripheral embolism. We describe a 49-year-old male patient with class III angina symptoms and extensive aortic plaque burden referred for coronary computed tomography angiography due to a high risk of catheterization-related cerebrovascular complications. On the basis of computed tomography angiography findings, the final decision on coronary artery bypass grafting with a modification of the surgical approach was made.
Trans-apical beating heart off-pump mitral valve (MV) repair is a novel surgical technique for treating mitral regurgitation (MR) caused by degenerative flail/prolapse (DLP).To present early outcomes of a single-center experience with transapical beating heart mitral valve repair with the NeoChord system.Thirty-seven patients with severe symptomatic MR were treated with the NeoChord technique between September 2015 and December 2018 (78% men; mean age: 62.3 ±13.4 years). We evaluated standard cardiac surgery perioperative complications as well as those related to the NeoChord technique as well as early surgical success as defined by the reduction of MR to less than moderate by implantation of at least 2 neochordae.During this series we had no hemodynamic instability due to bleeding or arrhythmia. There were no transapical technique-related adverse events such as a leaflet perforation or tear, a major native chord rupture, which would require implantation of a new chord, ventricular apex rupture, or left atrial perforation. There were no major adverse events including death, stroke or acute myocardial infarction. Nine (24%) patients developed an episode of perioperative atrial fibrillation. We were able to conclude the operation in 98% of our patients with less than moderate MR. One (2%) patient had moderate MR at the conclusion of the operation.Trans-apical off-pump MV repair with the NeoChord system is a safe, minimally invasive procedure, with few minor complications. In well-selected candidates it provides successful treatment of degenerative MR. Results are anatomy dependent, so preoperative patient selection is crucial.
Minimally invasive techniques of mitral valve (MV) repair have been increasingly used in recent years. Transapical implantation of artificial chordae on a beating heart under 2D/3D transesophageal echocardiographic guidance with the NeoChord DS1000 device is a new surgical treatment of degenerative mitral regurgitation (MR).To evaluate early results of MV repair with the NeoChord DS1000 device in the first group of consecutive patients operated on in Poland.Twenty-one patients with severe MR due to posterior leaflet prolapse (81% male; mean age: 60.7 ±12.7 years) underwent MV repair with the NeoChord DS1000 system. There were 12 (57.1%) patients with type A (an isolated central prolapse/flail), 8 (38.1%) patients with type B (multisegment disease/flail) and 1 (4.8%) patient with type C (posterior/paracommisural area) MV prolapse. A flail leaflet was present in 12 (57.1%) patients. The median number of neochords was 3 (2-6). We assessed by echocardiography left-sided heart morphology and evaluated MR degree before and 6 months after chords implantation.Early procedural success was achieved in 100% of patients. At the 6-month follow-up nonsignificant MR (trace and mild) was detected in 17 (81.0%) patients, while moderate MR was detected in 4 (19.0%) patients; mean values of left-sided heart dimensions and volumes, mitral E and E' velocity of lateral MV annulus significantly decreased.A novel procedure with the NeoChord DS1000 device is feasible in properly selected patients, and results in a significant reduction of MR degree and left ventricle and left atrium reverse remodeling at the 6-month follow-up.
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Kurnicka K, Wróbel K, Zieliński D, Juraszyński Z, Biederman A, Pruszczyk P. Three-dimensional transoesophageal echocardiographic imaging for support of minimally invasive robotic mitral valve repair using the da Vinci system – first experience in Poland. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2019;15(3):382-384. doi:10.5114/aic.2019.87902. APA Kurnicka, K., Wróbel, K., Zieliński, D., Juraszyński, Z., Biederman, A., & Pruszczyk, P. (2019). Three-dimensional transoesophageal echocardiographic imaging for support of minimally invasive robotic mitral valve repair using the da Vinci system – first experience in Poland. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 15(3), 382-384. https://doi.org/10.5114/aic.2019.87902 Chicago Kurnicka, Katarzyna, Krzysztof Wróbel, Dariusz Zieliński, Zbigniew Juraszyński, Andrzej Biederman, and Piotr Pruszczyk. 2019. "Three-dimensional transoesophageal echocardiographic imaging for support of minimally invasive robotic mitral valve repair using the da Vinci system – first experience in Poland". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 15 (3): 382-384. doi:10.5114/aic.2019.87902. Harvard Kurnicka, K., Wróbel, K., Zieliński, D., Juraszyński, Z., Biederman, A., and Pruszczyk, P. (2019). Three-dimensional transoesophageal echocardiographic imaging for support of minimally invasive robotic mitral valve repair using the da Vinci system – first experience in Poland. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 15(3), pp.382-384. https://doi.org/10.5114/aic.2019.87902 MLA Kurnicka, Katarzyna et al. "Three-dimensional transoesophageal echocardiographic imaging for support of minimally invasive robotic mitral valve repair using the da Vinci system – first experience in Poland." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 15, no. 3, 2019, pp. 382-384. doi:10.5114/aic.2019.87902. Vancouver Kurnicka K, Wróbel K, Zieliński D, Juraszyński Z, Biederman A, Pruszczyk P. Three-dimensional transoesophageal echocardiographic imaging for support of minimally invasive robotic mitral valve repair using the da Vinci system – first experience in Poland. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2019;15(3):382-384. doi:10.5114/aic.2019.87902.
Rupture of the interventricular septum is a serious complication of myocardial infraction (MI). It occurs in 1-3% of all MI cases, usually within 2 weeks after infraction. In 60% of the cases post-MI ventricular septal defects (VSD) are the result of completely occluded coronary artery supplying anterior wall of left ventricle and subsequent transmural MI. 50% of patients die within the first week after the rupture unless they are surgically treated. In this case report we describe an 87-year-old woman with post-MI VSD who was successfully operated (endocardial patch exclusion technique, proposed by David). In spite of a very high predicted risk (97% by Euroscore), calculated high risk should not be considered as the contraindication for life-saving operation.
Artificial chord implantation to repair a flail or prolapsing mitral valve leaflet requires open heart surgery and cardiopulmonary bypass.Transapical off-pump artificial chordae implantation is a new surgical technique proposed to treat degenerative mitral valve regurgitation. The procedure is performed using the NeoChord DS1000 system (NeoChord, Inc., St. Louis Park, MN, USA), which facilitates both implantation and lenght adjustment of the artificial chordae under two (2D)- and three (3D)-dimensional transoesophageal echocardiographic (TEE) guidance on a beating heart.Two male patients aged 60 and 55 years with severe mitral regurgitation due to posterior leaflet prolapse underwent transapical off-pump artificial chordae implantation on September 3, 2015. The procedure was performed by left minithoracotomy under general anaesthesia in a cardiac surgical theatre, using 2D and 3D TEE guidance.Early procedural success as confirmed by 3D TEE was achieved in both patients, with implantation of 6 artificial chordae in the first patient and 3 artificial chordae in the second patient. Both procedures were uneventful, and no postoperative complications were noted. The patients were discharged home on the 8th and 6th postoperative day, respectively.The NeoChord DS1000 system allows both implantation and lenght adjustment of artificial chordae under 2D and 3D TEE guidance on a beating heart. Our initial experience in 2 patients with posterior mitral leaflet prolapse indicates that the procedure is feasible and safe.